Inicio › Esquizofrenia › Texas

Ensayos clínicos de Esquizofrenia en Texas

34 estudios sobre Esquizofrenia buscan participantes en Texas.

Ciudades en Texas

Texto oficial del estudio (inglés)

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

Haracec Clinical Research, El Paso
C-Trilogy Outreach, Longview

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07101094

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

Community Clinical Research, Inc., Austin
Pillar Clinical Research, LLC, Richardson

ReclutandoFase 1

Edades de 18 a 55 · Todos los sexos · Actualizado el 28 sept 2026 · NCT07615426

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

Local Institution - 0049, Austin
Local Institution - 0194, Dallas
Pillar Clinical Research - Richardson, Richardson

ReclutandoFase 3

Edades de 18 a 65 · Todos los sexos · Actualizado el 28 sept 2026 · NCT07686263

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Neurocrine Clinical Site, Austin
Neurocrine Clinical Site, DeSoto
Neurocrine Clinical Site, Houston

ReclutandoFase 3

Edades de 18 a 65 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07114874

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Neurocrine Clinical Site, DeSoto

ReclutandoFase 3

Edades de 18 a 65 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07227818

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

Texas Research Group, Coppell
PsyMed Solutions, Fort Worth
Kaleidoscope Clinical Research, Houston
y 3 más

ReclutandoFase 3

Edades de 5 a 17 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06229210

Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia

TG Therapeutics Investigational Trial Site, Richardson

ReclutandoFase 2

Edades de 18 a 60 · Todos los sexos · Actualizado el 23 sept 2026 · NCT07680946

A Study of Brenipatide in Adult Participants With Schizophrenia

Adams Clinical Dallas, DeSoto
Re:Cognition Health - Fort Worth, Fort Worth

ReclutandoFase 2

Edades de 18 a 55 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07410507

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

Local Institution - 0149, Dallas
VAST Clinical Research, Garland
Local Institution - 0169, Houston
y 2 más

ReclutandoFase 3

Edades de 5 a 17 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07424404

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Neurocrine Clinical Site, Austin

ReclutandoFase 4

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT07105111

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

Pillar Clinical Research, LLC, Richardson

ReclutandoFase 1

Edades de 18 a 55 · Todos los sexos · Actualizado el 17 sept 2026 · NCT07734493

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

The University of Texas Health Science Center, Houston, Houston

Reclutando

Edades de 22 a 65 · Todos los sexos · Actualizado el 16 sept 2026 · NCT05276050

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

Community Clinical Research - Cross Park Drive /ID# 272977, Austin
Pillar Clinical Research - Richardson /ID# 275715, Richardson

ReclutandoFase 2

Edades de 18 a 65 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07145918

52-week Open Label Safety-Tolerability Study

Adams Clinical, DeSoto
Pillar Clinical Research, Richardson

ReclutandoFase 3

Edades de 18 a 65 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

VAST Clinical Research, Garland
Local Institution - 0120, Houston
Local Institution - 0066, Spring

ReclutandoFase 3

Edades de 13 a 17 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

Community Clinical Research, Austin

ReclutandoFase 1

Edades de 18 a 55 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Clinical Site, Austin
Clinical Site, DeSoto
Clinical Site, Richardson

ReclutandoFase 2

Edades de 18 a 65 · Todos los sexos · Actualizado el 1 sept 2026 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

Local Institution - 0016, Austin
Local Institution - 0050, Dallas
Local Institution - 0021, Fort Worth
y 10 más

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT07379827

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

BioXcel Clinical Research Site, DeSoto

ReclutandoFase 1

Edades de 10 a 17 · Todos los sexos · Actualizado el 11 ago 2026 · NCT05025605

Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia

The University of Texas Health Science Center at Houston, Houston

Reclutando

Edades de 18 a 60 · Todos los sexos · Actualizado el 5 ago 2026 · NCT07060066

Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment

The University of Texas Health Science Center at Houston, Houston

Reclutando

Edades de 18 a 50 · Todos los sexos · Actualizado el 3 ago 2026 · NCT02916810

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)

The University of Texas Health Science Center, Houston, Houston

Reclutando

Edades de 18 a 60 · Todos los sexos · Actualizado el 7 jul 2026 · NCT06345963

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)

The University of Texas Health Science Center, Houston, Houston

Reclutando

Edades de 18 a 60 · Todos los sexos · Actualizado el 7 jul 2026 · NCT06961916

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Community Clinical Research, Austin

ReclutandoFase 2

Edades de 18 a 55 · Todos los sexos · Actualizado el 23 jun 2026 · NCT07191483

Deep Brain Stimulation for Psychosis

UT Southwestern Medical Center, Dallas

Reclutando

Edades de 22 a 70 · Todos los sexos · Actualizado el 9 jun 2026 · NCT06257056

A Study to Evaluate the Effect of KarXT on Urological Safety

Local Institution - 0001, Austin
InSite Clinical Research, DeSoto

ReclutandoFase 4

Edades de 18 a 65 · Todos los sexos · Actualizado el 3 jun 2026 · NCT07221877

CLOZAPINE Response in Biotype-1

UT Southwestern Medical Center, Dallas

ReclutandoFase 4

Edades de 18 a 60 · Todos los sexos · Actualizado el 11 may 2026 · NCT04580134

Database Registry for Neural Network Biomarkers in Psychosis

University of Texas Southwestern Medical Center, Dallas

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 18 a 60 · Todos los sexos · Actualizado el 23 abr 2026 · NCT01409109

Ocrelizumab for Psychosis by Autoimmunity

Houston Methodist Research Institute, Houston

ReclutandoFase 1/2

Edades de 18 a 35 · Todos los sexos · Actualizado el 1 abr 2026 · NCT03971487

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

University of Texas Southwestern Medical Center, Dallas

ReclutandoEstudio observacional

Edades de 18 a 40 · Todos los sexos · Actualizado el 10 mar 2026 · NCT06740383

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Neurocrine Clinical Site, Austin
Neurocrine Clinical Site, DeSoto
Neurocrine Clinical Site, Houston

ReclutandoFase 3

Edades de 18 a 65 · Todos los sexos · Actualizado el 6 mar 2026 · NCT06963034

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

University of Texas at Dallas, Dallas

Reclutando

Edades de 18 a 65 · Todos los sexos · Actualizado el 23 ene 2026 · NCT07098169

Randomized Withdrawal Study in Patients With Schizophrenia

Vanda Investigational Site, Austin
Vanda Investigational Site, Houston
Vanda Investigational Site, Irving
y 1 más

ReclutandoFase 3

Edades de 18 a 65 · Todos los sexos · Actualizado el 12 ene 2026 · NCT06961968

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Reviva site, Austin
Reviva site, Richardson

ReclutandoFase 3Se aceptan voluntarios sanos

Edades de 18 a 65 · Todos los sexos · Actualizado el 19 dic 2024 · NCT05184335

De ClinicalTrials.gov, datos obtenidos el 2 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.